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Adaptive mechanisms controlling uterine spiral artery
remodeling during the establishment of pregnancy
MICHAEL J. SOARES*, DAMAYANTI CHAKRABORTY, KAIYU KUBOTA,
STEPHEN J. RENAUD and M.A. KARIM RUMI
Institute for Reproductive Health and Regenerative Medicine, Department of Pathology and Laboratory Medicine,
University of Kansas Medical Center, Kansas City, Kansas, USA

ABSTRACT Implantation of the embryo into the uterus triggers the initiation of hemochorial
placentation. The hemochorial placenta facilitates the acquisition of maternal resources required
for embryo/fetal growth. Uterine spiral arteries form the nutrient supply line for the placenta and
fetus. This vascular conduit undergoes gestation stage-specific remodeling directed by maternal
natural killer cells and embryo-derived invasive trophoblast lineages.The placentation site, including
remodeling of the uterine spiral arteries, is shaped by environmental challenges. In this review, we
discuss the cellular participants controlling pregnancy-dependent uterine spiral artery remodeling
and mechanisms responsible for their development and function.
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Introduction
The embryo implants into the uterus to gain access to maternal nutrients. Delivery of nutrients is facilitated by the placenta,
which develops in association with the embryo/fetus. Trophoblast
cells are the functional units of the placenta and key contributors
to establishing the maternal-fetal interface. Hemochorial is the
categorization of placentation displaying the closest connections
between maternal and fetal tissues (Amoroso 1959; Mossman
1987; Wooding and Burton 2008). Maternal blood directly bathes
trophoblast, which requires restructuring of the uterine spiral
arterial tree. Distal segments of the uterine spiral arterial tree
are targeted and structurally modified to create conduits with
altered vasoregulation properties, maximizing the flow of maternal
resources to the placenta (Osol and Mandala 2009; Leonard et
al., 2013; Osol and Moore 2014). This represents an orchestrated
process involving the activities of specialized cell types derived
from trophectoderm (outer layer of the blastocyst-stage embryo)
and the modulatory influences of cells situated within the uterine
stromal compartment (Pijnenborg et al., 2006; Wallace et al.,
2012). The extent of pregnancy-dependent uterine spiral artery
remodeling differs among species (Amoroso 1959; Mossman 1987;
Wooding and Burton 2008) and aberrations in uterine vascular
modifications are associated with pregnancy-related diseases
(Pijnenborg et al., 2006; Wallace et al., 2012).

In this review, we discuss the cellular participants controlling pregnancy-dependent uterine spiral artery remodeling and
mechanisms responsible for their development and function.

Uterine spiral artery remodeling
Uterine spiral arteries are the conduits for delivering maternal
nutrients to the fetus. These blood vessels undergo restructuring
during the establishment of pregnancy (Pijnenborg et al., 2006;
Osol and Mandala 2009; Harris 2010). The maternal uterine spiral
arteries undergoes fundamental changes of their cellular (endothelial and smooth muscle cell) and extracellular constituents,
including hyperplasia, hypertrophy, apoptosis, dedifferentiation,
migration, and extracellular matrix remodeling (Osol and Mandala
2009; Harris 2011). We focus on two key architects of uterine
spiral artery remodeling: maternal natural killer (NK) cells and
invasive trophoblast cells of extraembryonic origin (Smith et al.,
2009; Harris 2011; Wallace et al., 2012). Other cell types, such
as maternal macrophages, also contribute to the remodeling
process (Smith et al., 2009). There is a temporal dependence
to NK cell and trophoblast contributions during pregnancy with
NK cells arriving and acting first followed by invasive trophoblast
Abbreviations used in this paper: NK, natural killer cell; TS, trophoblast stem cell.
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cells. Each cell type exhibits similarities and differences in their
tasks. Both NK cells and trophoblast cells target the extracellular
matrix and smooth muscle cells surrounding the spiral arteries
leading to an alteration of vasoregulation and the facilitation of
nutrient delivery (Wallace et al., 2012). Trophoblast cells go even
further and supplant the endothelium of distal arterial segments.
Subsequently, they assume a phenotype resembling the endothelium termed pseudo-vascularization (Damsky and Fisher 1998;
Rai and Cross 2014). The actions and effectiveness of these
specialized cell populations are guided through signals impinging
on the intrauterine environment. They react and adapt to appropriately direct formation of the maternal-fetal interface, balancing
the needs of the mother and fetus. Aberrations in NK cell and/
or invasive trophoblast cell performance lead to disruptions in
nutrient delivery to the placenta and subsequently to the embryo.

Models for studying mechanisms controlling uterine
spiral artery remodeling
Control systems regulating any aspect of the vascular network
can be complex and difficult to analyze. Uterine spiral artery remodeling is no exception. Human placentation exhibits extensive
uterine spiral artery remodeling guided through the actions of NK
cells and invasive trophoblast. Effective dissection of mechanisms
controlling uterine spiral artery remodeling requires a combined
in vivo and in vitro effort, which presents limitations for investigations of the in vivo pregnant human intrauterine environment.
There is an assortment of mammalian species adapted to laboratory research that possess hemochorial placentation and could
potentially be used to model uterine spiral artery remodeling;
however, all are not suitable. Although, hemochorial placentation

Fig. 1. Hemochorial placentation. Schematic diagram showing homologous structures within
human and rat hemochorial
placentation sites. In the human, trophoblast cells destined
for the maternal compartment
are referred to as extravillous
trophoblast cells, whereas in
the rat these cells are referred
to as invasive trophoblast cells.
Invasive trophoblast cells are
specialized into interstitial and
endovascular subtypes. Collectively, invasive trophoblast
cells and natural killer cells direct
uterine spiral artery restructuring.
Adapted from Soares et al., 2012.

exhibits elements of conservation across mammalian species, it
also shows striking differences, including a dearth of trophoblast
involvement in uterine spiral artery remodeling in some species,
notably the mouse (Adamson et al., 2002; Ain et al., 2003). In
contrast, placentation in other common laboratory species, including the rat, hamster, and guinea pig possess deep trophoblast
invasion not unlike that seen in human placentation (Pijnenborg
and Vercruysse 2010). The rat is an effective model for examining regulatory roles of both NK cells and invasive trophoblast
in uterine spiral artery remodeling (Soares et al., 2012; Fig. 1).
The rat is especially attractive because excellent in vitro and in
vivo approaches have been established for dissecting regulatory
pathways controlling placentation. Trophoblast stem (TS) cells
can be isolated from early embryos and readily propagated and
manipulated for experimentation on invasive trophoblast lineage
differentiation (Asanoma et al., 2011; Chakraborty et al., 2011;
Kent et al., 2011; Konno et al., 2011). The size of the rat presents advantages for surgical preparations and repeated tissue
sampling, and the rat can be genetically modified using newly
developed genome editing strategies (Jacob et al., 2010; Rumi et
al., 2014). These approaches coupled to complementary experimentation with ex vivo human tissues obtained from normal and
diseased placentation sites (Aplin 2006; Hunkapiller and Fisher
2008; Hazan et al., 2010; Robson et al., 2012), a collection of
immortalized human extravillous trophoblast cell lines (HTR-8/
SVneo, SGHPL-4/5, Swan 71; Graham et al., 1993; Whitley
2006; Straszewski-Chavez et al., 2009), and BMP4-treated human embryonic or induced pluripotent stem cells (Xu et al., 2002;
Ezashi et al., 2011; Amita et al., 2013; Li et al., 2013) provide a
robust toolset for dissecting conserved mechanisms regulating
the maternal-fetal interface.
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Natural killer (NK) cells
NK cells are constituents of the innate immune system possessing unique trafficking characteristics during pregnancy. Unlike
other immune cell lineages, NK cells accumulate at the implantation site. These NK cells possess a unique phenotype and are
distinct from circulating NK cells (Koopman et al., 2003; Cerdeira
et al., 2013). They are embedded in the decidua and establish
conspicuous relationships with uterine spiral arteries and invasive
trophoblast cells, a process conserved among rodents and primates
(Chakraborty et al., 2011; Zhang et al., 2011; Dambaeva et al.,
2012). NK cell deficient animal models have been used to demonstrate the involvement of NK cells in uterine spiral artery remodeling (Guimond et al., 1997; Barber and Pollard 2003; Chakraborty
et al., 2011). This assessment has been supported by co-culture
experiments involving NK cells and uterine spiral artery segments
(Robson et al., 2012). NK cells contribute to pregnancy-dependent
restructuring of the uterine spiral arteries, especially loss of tunica
media integrity, which facilitates fetal nutrient delivery. Infiltration,
differentiation, and maintenance of NK cells within the uterus during the establishment of pregnancy are influenced by interleukin
15, interleukin 11, Hoxa-10, transforming growth factor-b (TGFB),
bone morphogenetic protein (BMP), and adrenomedullin signaling
pathways (Barber and Pollard 2003; Ain et al., 2004; Rahman et
al., 2006; Keskin et al., 2007; Li et al., 2013; Nagashima et al.,
2013). NK cell effects on uterine spiral arteries may be mediated
by interferon g (Ashkar and Croy, 2001), nitric oxide (Hunt et al.,
1997), and an assortment of angiogenic growth factors and extracellular matrix modifying enzymes (Li et al., 2001; Wang et al.,
2000, 2003; Hanna et al., 2006; Lash et al., 2006b; Kopcow and
Karumanchi 2007; Wallace et al., 2012).
NK cells have also been implicated in the regulation of trophoblast cell invasion into the uterus and trophoblast cell interactions
with uterine spiral arteries. A range of direct actions of NK cells on
trophoblast cells has been postulated based primarily on in vitro
analyses. The outcomes of these experiments are not entirely
consistent and are likely influenced by the gestational age of the
specimens and culture conditions. Some studies provide evidence
for NK cell promotion of trophoblast migration and invasiveness
(Hanna et al., 2006; Lash et al., 2010; Wallace et al., 2013), whereas
other reports show that NK cells and their secretory products inhibit
these vital functions (Ain et al., 2003; Hu et al., 2006; Lash et al.,
2006a; Eastabrook et al., 2008). Furthermore some researchers
have advocated for the importance of physical interactions between
NK cells and invasive trophoblast cells. Specific patterns of polymorphic trophoblast cell surface ligands consisting of histocompatibility
antigen isoforms and their cognate polymorphic NK cell receptor
isoforms can define successful versus compromised pregnancies
(Hiby et al., 2004; Parham and Moffett 2013; Xiong et al., 2013;
Kieckbusch et al., 2014). These NK cell receptor-trophoblast cell
histocompatibility antigen interactions may be best developed in
primates (Parham and Moffett 2013). Direct signaling between
NK cells and trophoblast cells is intriguing; however, the indirect
actions of NK cells on trophoblast development via their effects
on the vasculature may be as compelling.
Pivotal insights into the roles of NK cells in the regulation of
hemochorial placentation were achieved using an in vivo rat model
(Chakraborty et al., 2011). An immunodepletion strategy was
employed to remove uterine NK cells during the establishment of

the hemochorial placenta. The resulting phenotype confirmed a
role for NK cells in the development and restructuring of uterine
spiral arteries and unexpected functions in modulating the invasive
trophoblast lineage. Surprisingly, trophoblast-directed uterine spiral
artery remodeling was accelerated and much more pronounced in
the absence of NK cells. The presence of NK cells also influenced
the trophoblast pseudovascular phenotype. Based on these observations it was proposed that any actions of NK cells in promoting
trophoblast endovascular invasion must be subtle and secondary
to an overall restraining function (Chakraborty et al., 2011). Furthermore, the NK cell inhibitory action was viewed as indirect through
NK cell regulation of uterine spiral artery development. Depletion
of NK cells limited uterine mesometrial vascular development,
lowering oxygen tension at the placentation site, and triggering
trophoblast lineage decisions favoring differentiation of the invasive
trophoblast lineage. Thus NK cell modulation of oxygen delivery
is viewed as a key signal impacting trophoblast invasiveness
and trophoblast-directed uterine spiral artery remodeling. These
insights required an in vivo test using the rat, a species with deep
trophoblast invasion.
Overview. NK cells have two key higher order functions regarding
hemochorial placentation. They collectively act as a pacemaker,
determining the timing of key developmental events and they
fine-tune placental morphogenesis, defining the allocation of trophoblast lineages and thus the structure/function features of the
placenta. The operative NK cell functions are to delay and restrict
the invasive trophoblast program. In performing these tasks they
effectively protect the mother and prevent precocious and excessive
trophoblast invasion and restructuring of the uterine spiral arteries.

Trophoblast lineage development
Placentation is characterized by temporally and spatially relevant
differentiation of trophoblast cells. The first cellular specification
event during development occurs as totipotent cells of the embryo are allocated to an outer position (trophectoderm) versus
an inner position (inner cell mass; Cockburn and Rossant 2010).
Trophectoderm is destined for expansion as a multi-potential
trophoblast stem (TS) cell population and further differentiation
into specialized trophoblast cell types (e.g. invasive trophoblast,
syncytiotrophoblast, etc), whereas cells of the inner cell mass
retain a broader developmental potential, including the ability to
form embryonic and extraembryonic structures. Some regulatory
factors controlling trophoblast lineage determination, expansion,
and differentiation have been discerned (Roberts and Fisher 2011;
Pfeffer and Pearton 2012).
Extracellular signal control. Fibroblast growth factor (FGF)- and
BMP-mediated signaling pathways are key regulators of the trophoblast lineage. The FGF4-FGFR2 signaling pathway promotes
self-renewal in rodent TS cells (Tanaka et al., 1998; Abell et al.,
2009; Murohashi et al., 2010; Asanoma et al., 2011). These cells can
be maintained in a proliferative stem state or they can be induced
to differentiate into specialized trophoblast lineages (Tanaka et
al., 1998; Asanoma et al., 2011). A cocktail containing FGF4 and
either TGFB or activin is sufficient to maintain TS cells ex vivo in
a proliferative and undifferentiated state (Erlebacher et al., 2004;
Kubaczka et al., 2014). An in vivo corollary to the TS cell has been
identified in both rodent and human placentation sites (Rielland et
al., 2008; Hemberger et al., 2010; Roberts and Fisher 2011; Pfef-
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fer and Pearton 2012). However, the presumptive human TS cell
population has not been successfully propagated ex vivo. There
have been some attempts at isolating and culturing TS/trophoblast
progenitor cell populations (Genbacev et al., 2011; Takao et al.,
2011). These cells self renew and possess some capacity to differentiate into specialized trophoblast cell types; however, they exhibit
a very different gene expression profile than do rodent TS cells or
the putative TS cells identified in the human placenta (Hemberger
et al., 2010). BMP4 is a downstream target of the FGF4-FGFR2
pathway in rodent TS cells (Murohashi et al., 2010) and is also an
inducer of the trophoblast lineage when presented to pluripotent
stem cells (Xu et al., 2002; Ezashi et al., 2012; Amita et al., 2013;
Li et al., 2013). Following BMP4 treatment, pluripotent stem cells
exhibit features of specialized differentiated trophoblast lineages.
Presumably a multipotent TS cell population arises as the pluripotent
stem cells commit to the trophoblast lineage; however, these cells
have not yet been captured and propagated ex vivo. Expansion of
such a cell population may require supplementation with special
TS cell sustaining factors that are yet to be identified. The power
of this pluripotent stem cell system for studying development of the
trophoblast lineage is twofold: i) trophoblast development of the
pluripotent stem cells is activated by BMP4, a known physiological regulator of trophoblast lineage determination (Hayashi et al.,
2010; Amita et al., 2013; Home et al., 2013; Li et al., 2013) and
ii) the model system is a window into the development of human
trophoblast (Ezashi et al., 2012).
Transcriptional/epigenetic control. During trophoblast lineage
determination, key factors sustaining the totipotent state are
repressed and/or downregulated, while other key factors supporting the trophoblast lineage are activated and/or upregulated.
These factors include transcription factors, histone modifiers, and
chromatin organizers. POU5F1 (also called OCT4) is an essential
transcription factor promoting totipotency and inhibiting trophoblast lineage development, whereas transcription factors such as
TEAD4, CDX2, and EOMES are critical for development of the
trophoblast lineage (Roberts and Fisher 2011; Pfeffer and Pearton
2012). Ectopic expression of any of
these three transcription factors can
convert pluripotent mouse embryonic
stem cells into TS cells (Niwa et al.,
2005; Tolkunova et al., 2006; Nishioka
et al., 2009). TEAD4 is an upstream
regulator of CDX2 and CDX2 is
an upstream regulator of EOMES.
SOX2, ESRRB, and TCFAP2C are
essential for TS cell self-renewal

Fig. 2. Overview of the developmental
progression from a totipotent stem
cell to a multipotent trophoblast stem
(TS) cell to a specialized differentiated
trophoblast cell. Each step along the
developmental progression is controlled
by positive and negative modulatory factors. These factors can be characterized
as transcription factors, histone modifiers, and chromatin organizers (lists are
provided in boxes below each cell type).
See text for additional information.

(Adachi et al., 2013). These transcription factors and others,
including GATA3, ELF5, and ETS2 contribute to development of
the trophoblast lineage but their positions in the gene regulatory
network are not yet precisely defined (Tremblay et al., 2001; Wen et
al., 2007; Ng et al., 2008; Home et al., 2009, 2012; Keramari et al.,
2010; Kidder and Palmer 2010; Kuckenberg et al., 2010; Ralston
et al., 2010; Adachi et al., 2013; Choi et al., 2013). The actions of
these transcription factors are presumably mediated through the
delivery of enzymatic machinery that post-translationally modifies
histones creating chromatin states that are more favorable or less
favorable for transcription. Modulation of histone post-translational
modifications has been implicated in the regulation of TS cell
stemness and differentiation (Yeap et al., 2009; Yuan et al., 2009;
Alder et al., 2010; Rugg-Gunn et al., 2010; Santos et al., 2010;
Abell et al., 2011; Chuong et al., 2013; Saha et al., 2013). Collectively, each of these transcription factor and histone modifier
activities is coordinated by a higher order of regulation controlled
by chromatin organizers. SATB1 and SATB2 are prototypical
genome organizers and have been implicated in controlling the
TS cell stem state (Asanoma et al., 2012). Trophoblast lineage
specific differentiation requires the downregulation of factors that
maintain the TS cell stem state and activation of regulatory factors
that promote lineage-specific differentiation. For example, CDX2,
EOMES, SOX2, ID1/2, ESRRB, ELF5, and SATB1/2 sustain the
TS cell stem state and are downregulated during differentiation
(Tanaka et al., 1998; Janatpour et al., 2000; Ralston et al., 2010;
Asanoma et al., 2011; Adachi et al., 2013), whereas transcription
factors such as GCM1, GATA2, ASCL2, FOSL1, JUNB, BHLHE40,
and OVOL2 are activated and promote differentiation into mature
sub-lineages (Tanaka et al., 1998; Janatpour et al., 1999; SchorppKistner et al., 1999; Schreiber et al., 2000; Hughes et al., 2004;
Ray et al., 2009; Asanoma et al., 2011; Kent et al., 2011; Ueno et
al., 2013; Renaud et al., 2014; Zhu et al., 2014). A schematic of
the progression from a totipotent stem cell to a multipotent TS cell
to a specialized differentiated trophoblast cell is shown in Fig. 2. In
summary, transcription factors, histone modifiers, and chromatin
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organizers cooperate to control totipotent stem cells, multipotent
TS cells, and specialized trophoblast cells (Hemberger 2010;
Maltepe et al., 2010; Wang et al., 2010; Rugg-Gunn 2012; Latos
and Hemberger 2014; Paul and Knott 2014).

Invasive trophoblast program
The development of trophoblast cells is multi-directional.
Trophoblast can specialize into cells with transport, hormone
secreting, and invasive features. Cells exhibiting invasive capabilities are termed invasive trophoblast or in the case of the human
as extravillous trophoblast. Invasive trophoblast cells possess
gene expression profiles distinguishing themselves from other
trophoblast cell lineages (Bilban et al., 2010; Apps et al., 2011).
Two phenotypically distinct types of invasive trophoblast can be
identified: i) cells moving between uterine stromal cells termed
interstitial invasive trophoblast cells and ii) cells moving within
uterine spiral arteries termed endovascular invasive trophoblast
cells (Pijnenborg et al., 2006). In rodents, interstitial invasive
trophoblast cells are characterized by their accumulation of glycogen (Teesalu et al., 1998; Vercruysse et al., 2006). Interstitial
invasion is severely restricted in some rat strains, including the
Brown Norway rat, which may be due to uterine progesterone
resistance and attenuated decidua development (Konno et al.,
2007, 2010, 2011). Both interstitial and endovascular invasive
trophoblast cells contribute to uterine spiral artery modifications;
however, based on their positioning they each have some unique
targets and modes of action. Interstitial invasive trophoblast cells
via their distribution throughout the uterine stroma likely possess a
broad set of actions supportive of the maternal-fetal interface. The
activities of endovascular invasive trophoblast cells are focused
on the vasculature. They breach the spiral artery wall and propel
themselves within the lumen of the vessel, where they replace
the endothelium and can mimic components of an endothelial cell
phenotype (Damsky and Fisher 1998; Rai and Cross 2014). There
are species differences in this process and evidence that trophoblast replacement of the endothelium is incomplete, transitory,
and that endothelial cells can repopulate the lining of the vessel
wall (Pijnenborg et al., 2006; Ockleford 2010). Migratory features
of invasive trophoblast are associated with their expression of
proteins facilitating movement, including those proteins capable
of modifying extracellular matrices. The mode of movement of
interstitial versus endovascular trophoblast differs. In interstitial
invasion – trophoblast cells dissociate and display elements of an
epithelial to mesenchymal transformation as they penetrate the
decidual stroma (Vicovac and Aplin 1996), whereas in endovascular
invasion – cells maintain connectivity and exhibit an epithelial to
endothelial-like transformation (Damsky and Fisher 1998). Aspects
of the invasive trophoblast cell phenotype can be modeled in vitro;
however, distinctions between the types of invasive trophoblast
cells are more difficult to discern and are generally associated with
acquisition of pseudovascular characteristics, which defines the
endovascular invasive trophoblast cell population.

Regulation of invasive trophoblast differentiation
Considerable attention has been directed to elucidating pathways controlling the invasive trophoblast lineage. In this section,
our discussion will be restricted to examples of conserved regula-

tion demonstrated in vitro and in vivo using animal model systems
and if available complemented with experimental findings showing
relevance to human implantation/placentation.
Phosphatidylinositol 3-kinase/AKT/FOSL1
Several years ago, a linkage between Src family nonreceptor
tyrosine kinases and phosphatidylinositol 3-kinase (PI3K) was
established in differentiating rat TS cells (Kamei et al., 1997,
2002). PI3K is an intracellular enzyme responsible for the phosphorylation of phosphatidylinositol, which serves as a downstream
activator of a signaling cascade controlling cell proliferation, differentiation, motility, metabolism, and survival (Cantley 2002). The
LYN nonreceptor tyrosine kinase associates with PI3K and both
proteins exhibit increases in enzymatic activity during trophoblast
differentiation (Kamei et al., 1997, 2002; Kent et al., 2010). Small
molecule inhibition of PI3K inhibits both endocrine and invasive
activities of differentiating rat TS cells (Kamei et al., 2002; Kent et
al., 2010). PI3K is an upstream regulator of the serine/threonine
kinase, AKT. Inhibition of AKT also interferes with activation of the
invasive trophoblast cell phenotype (Kent et al., 2011). AKT consists
of three isoforms (AKT1, AKT2, AKT3). Each isoform is expressed
in differentiating trophoblast cells and contributes to regulating the
invasive trophoblast lineage (Kent et al., 2011). Both shared and
isoform-specific actions characterize AKT signaling in differentiating
trophoblast leading to complexities not yet fully appreciated (Kent
et al., 2011; Haslinger et al., 2013).
There are numerous potential upstream activators of the PI3K/
AKT signaling cascade in trophoblast cells, consisting of growth
factors, cytokines, and extracellular matrix constituents (Polheimer
and Knöfler 2005; Knöfler 2010). EGF, HGF, IGF2, chorionic gonadotropin, and wingless (WNT) family ligands have been shown
to stimulate invasive properties of human trophoblast or trophoblast
cell lines, at least in part, through activation of the PI3K/AKT signaling pathway (Cartwright et al., 2002; Qiu et al., 2004; Prast et al.,
2008; Sonderegger et al., 2010; Pollheimer et al., 2011; Haslinger
et al., 2013). However, demonstration of the involvement of any of
these activators of PI3K/AKT in the regulation of in vivo intrauterine
trophoblast invasion is lacking.
One intriguing downstream mediator of PI3K/AKT regulation of
trophoblast invasiveness is the activator protein 1 (AP1) transcription factor component, FOSL1. PI3K/AKT signaling stabilizes the
nuclear localization of FOSL1 (Kent et al., 2011). Trophoblast gene
expression and invasion are regulated by FOSL1. In vitro knockdown
of FOSL1 using specific short hairpin RNAs (shRNAs) disrupts the
expression of key genes encoding proteins associated with dissolution of extracellular matrices, cell migration, and vascular remodeling
and inhibits trophoblast cell migration through extracellular matrices
(Kent et al., 2011). Furthermore, in vivo knockdown of FOSL1 in the
rat using trophoblast-specific lentiviral delivery of specific FOSL1
shRNAs significantly reduced the depth of trophoblast invasion
into the uterus (Kent et al., 2011). Such an action of FOSL1 was
not evident from mouse mutagenesis experiments (Schreiber et
al., 2000). FOSL1 was shown to regulate mouse placentation but
a clue to its actions on the invasive trophoblast lineage was not
forthcoming. These results do not diminish FOSL1 as a regulator
of the invasive trophoblast phenotype but instead highlight the
limitations of using the mouse as a model system for investigating
the invasive trophoblast lineage. In fact, the pro-invasive action of
FOSL1 is conserved in human trophoblast (Renaud et al., 2014).
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FOSL1 is localized to extravillous trophoblast at the leading edge
of trophoblast columns penetrating the uterine decidua. Interestingly, two other FOS family transcription factors, FOS and FOSB,
restrain the actions of FOSL1 and instead are prominently expressed
in proliferating trophoblast cells embedded within the core of the
trophoblast columns (Renaud et al., 2014).
Collectively, the data suggest the participation of a conserved
PI3K/AKT/FOSL1 pathway in the regulation of invasive trophoblast.
Upstream activation of PI3K/AKT signaling and downstream events,
including FOSL1 partners and specific transcriptional targets, mediating invasive trophoblast differentiation remain to be elucidated.
Notch
The Notch signaling pathway is a highly conserved cell-cell
communication system directing embryonic development. Notch
signaling components include a family of receptors (NOTCH1-4)
and membrane-associated ligands of the DLL and JAG families
(Hori et al., 2013). Signal transduction is activated when a ligandexpressing cell apposes a NOTCH-expressing cell impacting
potentially a broad spectrum of cellular processes (e.g. survival,
proliferation, differentiation, motility, and vascular specification).
Mouse and human trophoblast cells express components of the
Notch signaling pathway (Nakayama et al., 1997; Hunkapiller et al.,
2011; Haider et al., 2014). Selective genetic inactivation of Notch2
in mouse trophoblast lineages results in disruptions in placentation,
including failed trophoblast cell invasion of uterine spiral arteries
and impaired perfusion of the placenta (Hunkapiller et al., 2011). In
vitro experimentation has demonstrated the importance of Notch
signaling in human trophoblast cell biology but led to differing conclusions. In one report, disruption of Notch signaling with a small
molecule inhibitor interfered with trophoblast invasive properties
and impaired acquisition of a pseudo-vascular phenotype directly
supporting the Notch2 mutant mouse phenotype (Hunkapiller et al.,
2011), whereas another report highlighted the importance of Notch
signaling in maintaining trophoblast proliferation and its antagonism
of trophoblast motility and invasive properties (Haider et al., 2014).
These in vitro experimental outcomes point to the importance of
Notch signaling in trophoblast cells and also its dynamic nature.
Multiple NOTCH receptors and ligands expressed by several placentation site-associated cell types each possessing gestational
stage-specific expression profiles creates complexities for planning
in vitro experiments designed to recapitulate aspects of in vivo
trophoblast cell development.
Oxygen
Cells require oxygen and possess intricate and highly conserved
mechanisms for adapting to oxygen deprivation (Semenza 2010).
Central to cellular adaptations to low oxygen is a transcriptional
complex referred to as hypoxia-inducible factor (HIF). HIF is composed of an oxygen labile alpha subunit (HIF1A or HIF2A) and a
constitutive partner referred to as HIF1 beta (HIF1B, also called aryl
hydrocarbon nuclear translocator, ARNT). The HIF alpha subunit is
vulnerable to degradation at oxygen replete conditions. In contrast,
at conditions of oxygen scarcity the HIF transcriptional complex is
stabilized and activates target genes encoding proteins essential
for cellular adaptation to low oxygen. Definitions of a couple of
terms associated with oxygen homeostasis are required before
we proceed. Normoxia represents a condition of “normal” oxygen
availability. Hypoxia is a condition associated with low oxygen ten-

sion, especially one that evokes the HIF-mediated cellular adaptive
response. Importantly, a specific oxygen tension cannot be used
to define hypoxia or normoxia. These are relative terms and are
absolutely dependent upon cell type and physiological or pathological setting. It should be appreciated that under physiological conditions hypoxia is a transient homeostatic process corrected by an
assortment of cellular and systemic adaptations. Chronic hypoxia
is a pathological event associated with failures in adaptation. These
fundamental principles need to be considered in designing experiments to investigate the impact of oxygen tension on trophoblast
cell biology. Unfortunately, attempts to model hypoxia in vitro have
been fraught with numerous inaccurate assumptions and misleading interpretations (see Tuuli et al., 2011 for additional discussion).
Oxygen tensions at the placentation site change during the
course of gestation (Zamudio, 2003). Establishment of the hemochorial interface is the pivotal event determining trophoblast cell
oxygen exposure. Oxygen increases once trophoblast-vascular
connectivity is established. It has also become evident that oxygen
is an orchestrator of placental morphogenesis (Dunwoodie 2009).
Such insight has been gained from mouse mutagenesis of several
key regulators of oxygen homeostasis, including HIF1A, HIF2A,
HIF1B, EGLN1, VHL, and CITED2 (Gnarra et al., 1997; Kozak et
al., 1997; Adelman et al., 2000; Cowden Dahl et al., 2005a; Maltepe
et al., 2005; Takeda et al., 2006; Withington et al., 2006). Additional
understanding has been achieved from using oxygen tension as an
in vivo experimental tool to investigate placentation site-associated
adaptations in the rat (Rosario et al., 2008). Exposure of pregnant
rats to 10-11% oxygen from the onset of embryo implantation
until midgestation results in profound effects on the maternal-fetal
interface (Ho-Chen et al., 2007; Rosario et al., 2008). The hypoxic
conditions drive increases in uterine mesometrial vascularity, uterine
spiral arterial remodeling, and dramatic increases in the depth of
intrauterine endovascular invasive trophoblast cell penetration (Fig.
3). This environmental challenge accelerated and exaggerated
changes at the placentation site that would not normally occur until
the latter stages of pregnancy. Activation of the invasive trophoblast
lineage required exposure to hypoxia between gestation days 8.5
and 9.5. This critical window of in vivo sensitivity to oxygen correlates with the initiation of essential trophoblast cell differentiation
leading to formation of the bi-compartmental rat placenta. Hypoxia
results in preferential expansion of the junctional zone and its resident invasive trophoblast cell population, which is situated at the
maternal interface, and a proportional reduction in the size of the
labyrinth zone (Rosario et al., 2008; Chakraborty et al., 2011). This
is a conserved adaptive response. In vivo hypoxia activation of the
invasive trophoblast lineage has also been observed in primates
(Zhou et al., 1993; Kadyrov et al., 2003). Alternatively, others have
used in vivo chronic hypoxia to overwhelm adaptive responses and
create placental injury (Tomlinson et al., 2010; Lai et al., 2011). Thus,
oxygen availability can serve as context-dependent instructive or
pathological signals affecting placentation. In general, trophoblast
cells migrate toward higher oxygen tensions (Jauniaux et al., 2001).
Oxygen tension is also a potent regulator of in vitro trophoblast
cell behavior, including development of the invasive trophoblast
lineage. Fisher and colleagues first showed that low oxygen tension
(2 percent) promoted first trimester human trophoblast proliferation,
whereas atmospheric oxygen (21 percent at sea level) stimulated
differentiation (Genbacev et al., 1996, 1997). Since then an assortment of observations have been made on trophoblast cell
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responses to low oxygen, including seemingly contradictory findings. It is now apparent that oxygen concentration and duration of
exposure can have fundamentally different effects on trophoblast
cell behavior (Tuuli et al., 2010; Zhou et al., 2011). Additionally,
the origin and characteristics of the trophoblast cell (e.g. primary
trophoblast, gestational age, immortalized trophoblast cell line,
trophoblast cancer cell) influences its responses to oxygen availability. Rodent TS cells have proven to be a robust in vitro model
system for studying trophoblast cell adaptations to low oxygen
(Cowden Dahl et al., 2005a,b; Chakraborty et al., 2011; Zhou et
al., 2011). Gradients in oxygen tension can differentially stimulate
trophoblast cell proliferation or trophoblast cell differentiation (Zhou
et al., 2011). Very low oxygen concentrations (0.5-1.5%) activate
development of the invasive trophoblast lineage (Cowden Dahl et
al., 2005b; Chakraborty et al., 2011). This differentiation event is
associated with decreased cell-cell adhesion, upregulation of matrix metalloproteinases, and increased cellular movement through
extracellular matrices; and is dependent upon activation of the HIF
signaling pathway. The targets downstream of HIF transcriptional
regulation in hypoxia-exposed TS cells have not been identified but
should include genes controlling key stages in the differentiation of
the invasive trophoblast lineage and also the activation of homeostatic regulatory processes designed to promote trophoblast cell
survival and function. Activation of endothelial nitric oxide synthase
and production of nitric oxide is an adaptation used in the mouse
placenta to prevent local hypoxia (Schaffer et al., 2006). There is
also evidence that non-canonical HIF signaling contributes to the
regulation of trophoblast differentiation (Choi et al., 2013) and that
hypoxia can affect trophoblast differentiation independent of HIF
(Tache et al., 2013). Links between hypoxia and epigenetic regulation, including histone acetylation and DNA methylation, have been
investigated in trophoblast cells (Maltepe et al., 2005; Yuen et al.,
2013). Interestingly, in human trophoblast cells hypoxia-sensitive
DNA methylation regions are enriched for AP1 binding motifs (Yuen
et al., 2013), thus potentially connecting AP1, including FOSL1,
and hypoxia/HIF regulatory pathways in trophoblast cell adaptive
mechanisms.
In summary, TS cells present during the formative stages of

placentation are characterized by their plasticity. They can differentiate into trophoblast cells targeted to the uterine vasculature or
alternatively into trophoblast cells dedicated to nutrient transport,
effectively establishing the functional limits for placental performance
and the milieu for fetal growth and development. Oxygen delivery
to the TS cell niche contributes to decision-making governing trophoblast cell differentiation. Low oxygen activates HIF signaling
and favors differentiation directed toward the invasive trophoblast
cell lineage. Thus factors controlling oxygen delivery to the TS cell
niche, especially NK cells (see above), have a major influence on
the organization of the maternal-fetal interface.

Disease processes associated with disruptions in uterine
spiral artery remodeling

Failures in trophoblast-directed uterine spiral artery remodeling
have been reported in diseased human pregnancies diagnosed with
preeclampsia, Hemolysis, Elevated Liver enzymes, Low Platelets
(HELLP) syndrome, and intrauterine growth restriction (Kaufmann
et al., 2003; Pijnenborg et al., 2006). These pathologies have been
a major driver of placental research. There are exquisite descriptions
of the phenomenology surrounding the diseases but much less
insight into their actual etiologies. The lack of progress is certainly
associated with the multifactorial nature of any pregnancy related
event. The embryo, its ability to give rise to multiple trophoblast
lineages, and the host maternal environment in which the embryo
develops each contribute to the manifestation of the disease. Two
routes of inquiry are apparent: i) identify potential sensitive junctures
in normal developmental processes, which may impact susceptibility to disease; ii) directly study the disease and determine how the
disruption of candidate regulators leads to disease. Strategies for
studying trophoblast-directed uterine spiral artery remodeling have
been provided above. Investigations on mechanisms underlying
pregnancy-related diseases are inherently confounded because
key events associated with the ontogeny of the disease pre-date
diagnosis. Diseased tissue specimens are affected by a failed
placentation (e.g. hypoxia, inflammation) and thus compromise
acquisition of mechanistic insights into etiology from any phenotypic
analysis. Genetic analyses have offered
an alternative approach (van Dijk and
A
B
Oudejans 2013).
Several genetic screens have been
performed to establish linkages between
pregnancy-related diseases associated
with impairments in trophoblast cell invasion and uterine spiral artery remodeling,
including preeclampsia and the HELLP
syndrome (van Dijk and Oudejans 2013).
Among these efforts, a couple of genes
have been pursued and complemented
with functional analyses leading to the
identification of previously unappreciated
Fig. 3. Maternal hypoxia stimulates trophoblast invasion into uterine spiral arteries of the rat.
regulatory pathways.
Wild-type female rats were mated to homozygous chbA-enhanced green fluorescent protein (EGFP)
transgenic male rats and exposed to an atmospheric oxygen tension (21 percent at sea level (A) or
hypoxia (10-11%; gestation day 6.5 to day 13.5 (B). Placentation sites were examined on gestation day
13.5 and uterine mesometrial compartments inspected for EGFP positive cells. Note that maternal hypoxia stimulated the invasion of extraembryonic-derived EGFP positive cells deep into maternal uterine
spiral arteries, representing a potentially effective placental-associated adaptation to an environmental
challenge. Scale bar, 0.5 mm. Adapted from Rosario et al., 2008.

Stox1
A polymorphism at the STOX1 locus
was identified in genetic screens of
families with severe preeclampsia and
intrauterine growth restriction (van Dijk et
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al., 2005). The STOX1 protein possesses a winged helix domain
present in FOX family transcription factors, suggesting that STOX1
may contribute to the regulation of gene expression. The polymorphism affects the amino acid structure of the STOX1 DNA binding
domain (Y153H). The H isoform is associated with the diseased
state. It is expressed in extravillous trophoblast and specifically
targets and promotes transcription of the CTNNA3 gene. CTNNA3
encodes a cell-cell adhesion molecule, a-T-catenin, and restrains
the invasive properties of trophoblast cells (van Dijk et al., 2010).
These observations are further supported by experiments using
a transgenic mouse model. Pregnant female mice possessing
conceptuses overexpressing STOX1 exhibit preeclampsia-like
symptoms (Doridot et al., 2013). Although placentation was altered in the STOX1 overexpressing conceptuses, a description
of invasive trophoblast cells and uterine spiral artery remodeling
was not reported. Most interestingly, nuclear localization of the
STOX1 protein is regulated by AKT (van Dijk et al., 2010). AKTmediated STOX1 phosphorylation prevents entry of STOX1 into
the nucleus, consistent with the pro-invasive role of AKT signaling
in trophoblast cells.

methylates several circulating hormones, including catechol estrogens, and is responsible for the generation of 2-methoxyestradiol
(2-ME). 2-ME synergizes with hypoxia to promote trophoblast cell
invasive properties (Lee et al., 2010). Preeclamptic patients exhibit
decreased placental COMT activities and disruption of the Comt
gene in the mouse is associated with a preeclampsia-like phenotype in pregnant mice (Kanasaki et al., 2008). Polymorphisms in
the COMT gene affecting COMT expression or COMT enzymatic
activity may contribute to the development of preeclampsia (Shenoy et al., 2010). In contrast, the CORIN-associated preeclamptic
phenotype reflects disruptions in the maternal environment. CORIN is expressed in the uterus and acts to generate biologically
active atrial natriuretic peptide (ANP). ANP stimulates in vitro
trophoblast cell invasion through extracellular matrices and either
CORIN or ANP deficiencies in the mouse result in deficits in both
trophoblast invasion and uterine spiral artery remodeling and are
characterized by preeclamptic-like symptoms (Cui et al., 2012).
Uteri from preeclamptic patients express less CORIN and some
preeclamptic patients possess polymorphisms negatively affecting

HELLP long non-coding RNA
A genetic screen of familial HELLP
syndrome led to the identification
of mutations in a gene encoding a
long non-coding RNA specifically
expressed in extravillous trophoblast
(van Dijk et al., 2012). Initial evidence
indicates that the HELLP long noncoding RNA promotes proliferation
and inhibits differentiation into the
extravillous invasive trophoblast
phenotype. This finding opens an
avenue for future exploration into a
potentially novel mechanism controlling trophoblast differentiation.
Other candidate genes
A candidate gene approach has
also been used to elucidate mechanisms associated with disruptions
in trophoblast cell invasion and
preeclampsia. Two examples will
be discussed. Experimental evidence has accumulated suggesting
that catechol-O-methyltransferase
(COMT) and corin serine peptidase
(CORIN) are modulators of trophoblast cell invasion and disrupted in
preeclampsia (Kanasaki et al., 2008;
Lee et al., 2010; Cui et al., 2012).
Their potential involvement in the
etiology of the pregnancy-associated
disease surfaced from examination
of tissues from preeclamptic patients
and has been bolstered through
phenotypic investigations of genetically modified rodent models. COMT
is expressed in the placenta and

Fig. 4. Trophoblast stem (TS) cell plasticity and placental disease. Environmental challenges, including
nutrient availability, at the maternal-fetal interface direct the decision-making of TS cells. TS cells possess
the capacity to self-renew, die, become quiescent, or differentiate into specialized trophoblast lineages. A
successful pregnancy is associated with robust and gestation stage-appropriate homeostatic responses to
environmental challenges resulting in effective organization of the placentation site, maternal adaptations
and normal progression of fetal development and healthy offspring. In contrast, we propose that placental
disease is associated with a TS cell that lacks plasticity and the ability to effectively adapt to environmental
challenges, which activates a positive feedback loop sustaining and potentially intensifying the environmental
challenge, resulting in failures in placentation and maternal, fetal, and postnatal compromise.
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CORIN enzymatic activity (Cui et al., 2012), further supporting a
role for CORIN in the etiology of preeclampsia.
Overview
Diseases affecting trophoblast invasion and uterine spiral artery
remodeling are examples of classic positive feedback paradigms.
Early failures in the process of uterine spiral artery remodeling lead
to hypoxia and inflammation that perpetuate and exacerbate the
deficits (Renaud et al., 2011; Cotechini et al., 2014) and are not
remedied until the pregnancy is terminated and the protagonist
placenta removed. It is expected that clarity will be achieved as
we gain insights into both the physiology and pathophysiology of
uterine spiral artery remodeling.

Final thoughts on adaptations at the maternal-fetal
interface
Plasticity and the ability to adapt to environmental challenges
are favorable attributes for pregnancy success (see Fig. 4). Intrinsic to any adaptation affecting pregnancy is the control of the
decision-making process directing multi-lineage differentiation
of trophoblast stem cell populations. These stem cells can selfrenew, die, become quiescent, or differentiate and assume one
of several specialized functions within the placenta. This flexibility
is gestation-stage dependent with greater capacity for adaptation
during early versus later phases of pregnancy and it ensures that
the placentation site is optimally organized to facilitate fetal growth
and development. Failures in early organizational decisions yield
rigidity and inability to effectively adapt to later challenges. The
entry points for understanding placentation site-associated plasticity are homeostatic mechanisms that all cells utilize to optimize
their survival when exposed to environmental stressors. Some
elements of this fundamental adaptive process can be modeled
in a dish and are most meaningful when complemented with
investigations using animal models (Bonney 2013; Clark 2014).
Logically, placental disease results when adaptive responses at
the implantation/placentation site fail or are inappropriate, thus
sustaining or intensifying the environmental challenge and leading
to maternal, fetal, and postnatal compromise. Determining whether
a placenta is destined for success or failure, especially considering
the importance of the placenta to the growth and development of
the fetus and its future postnatal health, is inherently complicated
but fundamental to improving human health.
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